osteonecrosi
seriou
condit
involv
bone
destruct
frequent
requir
surgic
treatment
rebuild
joint
abund
literatur
document
corticosteroid
relat
osteonecrosi
consensu
rel
risk
osteonecrosi
administr
steroid
via
parenter
oral
topic
inhal
rout
risk
import
prognost
indic
identif
conserv
intervent
potenti
reduc
morbid
associ
aggress
surgic
treatment
osteonecrosi
paper
provid
insight
establish
guidelin
relat
risk
develop
osteonecrosi
result
corticosteroid
use
case
studi
retrospect
studi
prospect
studi
human
differ
corticosteroid
vari
dosag
assess
case
osteonecrosi
secondari
system
administ
corticosteroid
andor
high
dose
daili
therapi
particularli
patient
underli
comorbid
includ
connect
tissu
diseas
hyperlipidemia
previou
trauma
previou
case
report
osteonecrosi
relat
inhal
topic
use
steroid
complic
fact
great
major
case
patient
also
treat
system
steroid
prior
develop
osteonecrosi
base
literatur
set
recommend
regard
risk
osteonecrosi
patient
steroid
formul
osteonecrosi
otherwis
known
ischem
necrosi
avascular
necrosi
asept
necrosi
bone
osteochondr
dissecan
bone
death
result
collaps
normal
architectur
skelet
framework
lead
signific
clinic
morbid
includ
progress
joint
pain
loss
function
common
caus
osteonecrosi
trauma
lead
mechan
interrupt
nutrient
deliveri
bone
mani
nontraumat
caus
associ
well
far
well
known
associ
relat
use
corticosteroid
iatrogen
caus
includ
alcohol
radiat
treatment
bisphosphon
use
possibl
even
cigarett
smoke
exist
etiolog
osteonecrosi
includ
anatom
deform
leggperthescalv
diseas
disloc
joint
slip
femor
capit
epiphys
osteonecrosi
also
report
occur
result
exposur
hyperbar
condit
tenuous
associ
condit
lipid
disord
exist
lipid
storag
diseas
even
pregnanc
list
potenti
caus
lengthi
beyond
scope
articl
focu
attempt
navig
extens
literatur
corticosteroid
associ
osteonecrosi
order
deciph
trend
risk
relat
corticosteroid
use
harvey
cush
first
recogn
advers
effect
hypercortisol
bone
tissu
earli
sinc
multipl
report
bone
death
increas
awar
potenti
develop
osteonecrosi
patient
corticosteroid
steroid
induc
osteonecrosi
fact
describ
numer
public
rang
case
report
prospect
studi
doubt
real
risk
osteonecrosi
steroid
use
howev
often
difficult
determin
extent
causal
steroid
use
osteonecrosi
mani
condit
use
treat
also
caus
predispos
osteonecrosi
inde
appear
signific
differ
incid
corticosteroid
induc
osteonecrosi
depend
underli
condit
corticosteroid
administ
also
clear
whether
risk
osteonecrosi
close
relat
cumul
dose
maximum
dose
durat
therapi
topic
inhal
oral
glucocorticoid
frequent
use
treatment
eczema
asthma
allerg
rhiniti
pulmonari
diseas
autoimmun
diseas
inflammatori
diseas
therefor
vital
identifi
particular
risk
complic
associ
corticosteroid
use
osteonecrosi
first
describ
renal
transplant
patient
undergo
immunoabl
immunosuppress
part
transplant
regiment
multipl
report
elucid
connect
publish
causeeffect
relationship
well
establish
earli
diagnosi
proven
problemat
major
patient
asymptomat
signific
damag
bone
occur
osteonecrosi
tend
occur
younger
activ
age
group
limit
treatment
option
advanc
diseas
earli
identif
vital
multipl
treatment
option
explor
osteonecrosi
present
best
option
prevent
complet
joint
replac
diagnosi
subject
earlier
stage
joint
becom
compromis
emphas
import
identifi
highrisk
patient
earli
possibl
incid
steroid
induc
osteonecrosi
estim
approxim
per
year
unit
state
steroid
induc
osteonecrosi
account
total
joint
replac
perform
annual
unit
state
approxim
patient
steroid
induc
osteonecrosi
except
sle
patient
make
younger
cohort
averag
age
steroid
induc
osteonecrosi
sinc
treatment
surgeri
individu
requir
multipl
surgeri
lifetim
male
femal
ratio
except
patient
underli
system
lupu
erythematosu
sle
higher
femal
proport
earli
diagnosi
essenti
prognosi
treatment
option
declin
diseas
progress
corticosteroid
use
fall
behind
trauma
common
etiolog
osteonecrosi
preval
rang
estim
million
american
requir
glucocorticoid
variou
condit
incid
steroid
induc
osteonecrosi
may
reach
depend
durat
dose
underli
diseas
commonli
affect
site
osteonecrosi
includ
femor
humer
head
osteonecrosi
occur
elsewher
well
includ
knee
femor
condyl
proxim
tibia
small
bone
foot
ankl
hand
includ
scaphoid
lunat
vertebra
boni
structur
face
onset
steroid
induc
osteonecrosi
usual
insidi
vagu
earli
stage
symptom
may
occur
week
year
cessat
steroid
use
pain
may
refer
exampl
osteonecrosi
femor
head
unilater
hip
pain
usual
present
symptom
pain
may
also
refer
groin
thigh
knee
buttock
contralater
hip
becom
affect
within
year
case
function
may
affect
well
mani
patient
present
pain
limp
aggrav
weight
bear
partial
reliev
rest
progress
pain
common
advanc
diseas
pain
also
present
rest
rang
motion
disabl
progress
late
stage
hip
arthroplasti
becom
immin
pharmacolog
intervent
suboptim
effect
limit
analges
sever
classif
system
propos
grade
sever
osteonecrosi
ficat
arlet
scheme
stage
revers
stage
denot
end
stage
diseas
irrevers
damag
medlin
search
publish
studi
key
word
osteonecrosi
corticosteroid
conduct
search
accompani
refer
total
studi
date
present
review
determin
pertin
discuss
studi
consist
anim
human
studi
human
literatur
includ
case
report
review
prospect
studi
retrospect
studi
takehom
messag
manuscript
review
particular
refer
pathogenesi
clinic
present
risk
factor
steroid
dose
associ
osteonecrosi
report
particular
risk
develop
osteonecrosi
receiv
high
dose
long
term
long
act
prepar
steroid
similarli
cumul
dose
also
report
signific
risk
pathogenesi
howev
multipl
studi
also
reflect
occurr
treat
short
cours
high
dose
steroid
rare
low
dose
short
durat
cours
includ
inhal
topic
prepar
anim
model
help
establish
caus
effect
relationship
steroid
dose
pathogenesi
immunolog
osteonecrosi
discuss
subsequ
articl
seri
osteonecrosi
motomura
et
al
describ
relationship
steroid
dose
osteonecrosi
rabbit
model
rabbit
treat
mgkg
methylprednisolon
mpsl
result
incid
osteonecrosi
respect
histolog
repar
tissu
around
osteonecrosi
site
observ
rabbit
mgkg
mpsl
observ
rabbit
mgkg
mpsl
hematolog
examin
hyperlipidemia
thrombocytopenia
appar
rabbit
receiv
mgkg
mpsl
overal
studi
highlight
statist
signific
associ
dose
osteonecrosi
occurr
suggest
hyperlipidemia
import
pathophysiolog
similarli
yamamoto
et
al
examin
effect
puls
dose
methylprednisolon
acet
bone
bone
marrow
tissu
rabbit
observ
format
osteonecrosi
week
fortythre
percent
rabbit
develop
osteonecrosi
multipl
site
fourth
week
inject
mgkg
methylprednisolon
factor
relat
alter
lipid
metabol
also
found
present
includ
fatti
liver
hyperlipidemia
intraoss
fat
embol
yang
et
al
studi
mous
model
steroid
induc
osteonecrosi
interestingli
author
found
discontinu
therapi
less
osteonecrot
continu
dexamethason
treatment
consist
possibl
benefit
steroid
holiday
seen
clinic
set
case
report
corticosteroid
induc
osteonecrosi
present
first
follow
group
larger
prospect
retrospect
case
seri
cohort
studi
divid
underli
disord
underli
diseas
high
report
preval
steroid
induc
osteonecrosi
includ
system
lupu
erythematosu
renal
transplant
bone
marrow
transplant
cardiac
transplant
lung
transplant
liver
transplant
acut
lymphocyt
leukemia
hodgkin
diseas
multipl
myeloma
undergo
chemotherapi
sever
acut
respiratori
syndrom
sar
multipl
sclerosi
neurosurg
patient
major
studi
corticosteroid
induc
osteonecrosi
report
sle
patient
renal
transplant
patient
studi
steroid
administ
differ
name
properti
halflif
rel
strength
order
facilit
comparison
tabl
outlin
differ
commonli
use
corticosteroid
shown
tabl
rel
potenc
relat
drug
halflif
biolog
halflif
word
effect
corticosteroid
may
persist
long
drug
dissip
sera
tissu
interpret
data
case
report
must
undertaken
care
glean
inform
regard
effect
exact
steroid
dose
durat
cumul
doserisk
relationship
prepar
develop
osteonecrosi
must
interpret
within
context
confound
factor
within
patient
pathogenesi
osteonecrosi
inde
like
relat
multihit
theori
predispos
host
addit
type
dosag
steroid
underli
condit
concurr
medic
lifestyl
variabl
alcohol
cigarett
smoke
like
confound
variabl
furthermor
given
volum
prescript
intraarticular
ia
intramuscular
im
topic
oral
inhal
steroid
low
number
isol
case
report
need
interpret
within
context
individu
patient
histori
final
sheer
varieti
prepar
dose
potenti
prescrib
multipl
physician
throughout
patient
lifetim
make
calcul
talli
exact
cumul
dose
steroid
difficult
fraught
potenti
error
list
predispos
risk
factor
osteonecrosi
shown
tabl
case
report
consist
patient
identifi
includ
tabl
patient
wide
rang
diseas
includ
idiopath
thrombocytopen
purpura
polycythemia
addison
nephrot
syndrom
inflammatori
bowel
diseas
alcohol
abus
renal
transplant
autoimmun
inflammatori
diseas
sle
mctd
dermatomyos
polymyos
rheumatoid
arthriti
psoriasi
malign
breast
cancer
post
radiat
hodgkin
lymphoma
bone
marrow
transplant
acut
lymphocyt
leukemia
bronchogen
carcinoma
asthma
allerg
rhiniti
neurosurg
patient
myasthenia
gravi
pregnanc
femor
head
commonli
involv
site
occur
patient
follow
knee
humer
head
ankl
commonli
associ
administ
rout
includ
intraven
iv
puls
steroid
follow
oral
rare
report
intramuscular
depot
n
topic
n
intraarticular
n
inhal
n
enema
n
steroid
induc
osteonecrosi
singl
dose
steroid
im
ia
subsequ
risk
osteonecrosi
particular
concern
examin
found
uncommon
case
report
isol
im
ia
inject
subsequ
osteonecrosi
remaind
report
iaim
associ
case
includ
concurr
subsequ
addit
steroid
rout
administr
inhal
oral
puls
topic
repeat
iaim
inject
interpret
case
report
osteonecrosi
link
topic
steroid
limit
describ
case
treat
long
term
topic
prepar
year
rough
cumul
dose
rang
wide
mg
prednison
equival
major
case
also
treat
addit
prepar
oral
inhal
steroid
thu
osteonecrosi
like
exceedingli
rare
phenomenon
topic
steroid
alon
like
occur
prolong
therapi
cumul
dose
concurr
use
addit
steroid
therapi
prepar
risk
osteonecrosi
inhal
steroid
concern
given
vast
number
steroid
inhal
prescrib
asthma
theori
cumul
dose
inhal
steroid
lifetim
could
add
sizeabl
amount
howev
conclus
regard
steroid
risk
difficult
draw
report
case
relat
inhal
steroid
case
concurr
subsequ
treat
oral
steroid
prior
diagnosi
osteonecrosi
though
studi
perform
recent
unapprov
commonplac
use
swallow
ultra
high
dose
inhal
steroid
specif
fluticason
dipropion
treat
eosinophil
esophag
increas
risk
osteonecrosi
patient
major
case
report
involv
high
dose
puls
steroid
dexamethason
methylprednisolon
follow
vari
durat
oral
steroid
daili
repetit
basi
cumul
dose
describ
report
rang
mg
prednison
equival
averag
mg
prednison
approxim
mg
oral
prednison
administ
within
short
window
place
patient
increas
risk
addit
parenter
administ
steroid
increas
risk
significantli
parenter
administ
steroid
often
discuss
term
serum
halflif
one
rememb
biolog
halflif
drug
often
significantli
exceed
serum
halflif
system
lupu
erythematosu
multiorgan
multisystem
autoimmun
diseas
steroid
essenti
aspect
therapi
steroid
induc
osteonecrosi
sle
well
establish
clinic
appar
patient
rise
nearli
asymptomat
imageproven
osteonecrosi
taken
account
typic
sle
patient
multijoint
onset
osteonecrosi
hip
common
site
follow
knee
shoulder
goal
amalgam
prospect
retrospect
cohort
studi
tri
establish
pattern
risk
steroid
dose
develop
osteonecrosi
sle
patient
summari
studi
present
tabl
cushingoid
appear
tend
occur
higher
longerterm
dose
steroid
therapi
studi
specif
note
correl
cushingoid
appear
develop
osteonecrosi
mont
et
al
studi
clinic
laboratori
factor
patient
system
lupu
erythematosu
identifi
subgroup
higher
risk
develop
osteonecrosi
patient
studi
sle
develop
osteonecrosi
found
signific
increas
cushingoid
bodi
habitu
vs
without
p
thrombophleb
vascul
cigarett
smoke
preeclampsia
similarli
gladman
et
al
mok
et
al
massardo
et
al
zizic
et
al
found
statist
signific
correl
osteonecrosi
cushingoid
appear
gladman
studi
howev
osteonecrosi
exist
sle
absenc
cushingoid
featur
dose
steroid
influenc
risk
develop
osteonecrosi
studi
compil
specif
record
address
daili
dose
corticosteroid
studi
studi
find
statist
signific
correl
daili
steroid
dose
mean
maxim
daili
dose
develop
osteonecrosi
interestingli
major
neg
associ
occur
paper
prior
duboi
et
al
first
recogn
connect
sle
develop
osteonecrosi
howev
find
relationship
steroid
dose
occurr
probabl
patient
receiv
high
dose
studi
done
mri
similarli
bergstein
et
al
smith
et
al
respect
found
correl
daili
steroid
dose
osteonecrosi
diamant
et
al
fail
find
correl
peak
dose
durat
cumul
dose
steroid
osteonecrosi
howev
sinc
studi
nakumura
et
al
echo
neg
correl
author
studi
conclud
statist
signific
differ
highest
daili
dose
steroid
osteonecrosi
nonosteonecrosi
group
p
though
pvalu
approach
signific
major
critic
studi
methylprednisolon
puls
therapi
report
includ
data
analysi
may
turn
led
neg
conclus
sinc
evid
clear
correl
mean
daili
dose
maxim
daili
dose
high
dose
steroid
therapi
develop
osteonecrosi
massardo
et
al
found
posit
correl
osteonecrosi
use
prednison
dose
greater
equal
mgday
note
high
dose
methylprednisolon
therapi
also
risk
factor
conclud
patient
develop
osteonecrosi
receiv
higher
dose
steroid
shorter
period
time
compar
develop
osteonecrosi
clearli
lower
dose
prednison
administ
longer
time
would
carri
compar
increas
risk
statist
signific
reach
mpsl
data
prednison
data
ono
et
al
found
iv
mpsl
puls
therapi
prednison
n
mgday
least
month
risk
factor
osteonecrosi
zonananacach
et
al
also
demonstr
risk
osteonecrosi
significantli
increas
exposur
high
dose
oral
prednison
found
month
exposur
mg
prednison
associ
fold
increas
risk
develop
osteonecrosi
metaanalysi
felson
et
al
posit
relationship
oral
prednison
dose
evalu
time
interv
month
subsequ
develop
osteonecrosi
author
suggest
steroid
dose
major
factor
predict
risk
osteonecrosi
oral
dose
effect
amount
increas
risk
avn
everi
mgday
rise
oral
steroid
first
month
therapi
interestingli
found
associ
singl
bolu
dose
steroid
use
oinuma
et
al
found
osteonecrosi
develop
occur
high
dose
corticosteroid
treatment
relat
highest
daili
dose
migliaresi
et
al
find
increas
osteonecrosi
methylprednisolon
treat
patient
even
though
accumul
highest
dose
mont
et
al
found
sle
patient
osteonecrosi
receiv
higher
maxim
prednison
dose
without
osteonecrosi
ueaareewongsa
et
al
found
use
steroid
record
maximum
mean
daili
dose
significantli
higher
osteonecrosi
group
compar
control
gladman
et
al
conclud
osteonecrosi
significantli
associ
use
steroid
correl
maxim
dose
steroid
per
day
multivari
analysi
use
steroid
statist
signific
final
mean
daili
dose
prednison
highest
month
therapi
mgday
mgday
patient
develop
osteonecrosi
mean
daili
prednison
dose
highest
singl
month
treatment
well
maxim
dose
consecut
month
therapi
significantli
higher
patient
osteonecrosi
studi
reflect
higher
daili
dose
posit
correl
osteonecrosi
develop
correl
higher
cumul
dose
develop
osteonecrosi
also
studi
sle
studi
comment
cumul
dose
studi
studi
find
associ
cumul
dose
studi
regard
posit
correl
mok
et
al
identifi
subject
osteonecrosi
found
cumul
dose
month
significantli
higher
sle
patient
osteonecrosi
vs
without
osteonecrosi
vs
month
vs
g
prednison
month
jaovisidha
et
al
found
patient
develop
osteonecrosi
longest
durat
corticosteroid
treatment
higher
cumul
dose
compar
patient
develop
osteonecrosi
small
cohort
patient
limit
conclus
thu
drawn
retrospect
case
control
seri
gladman
et
al
identifi
patient
osteonecrosi
total
sle
patient
data
analysi
determin
minim
posit
odd
ratio
cumul
dose
reach
statist
signific
weiner
et
al
found
corticosteroid
intak
first
year
diagnosi
sle
third
year
diagnosi
sle
significantli
greater
osteonecrosi
vs
nonosteonecrosi
group
felson
et
al
metanalysi
avail
look
differ
studi
underli
disord
includ
renal
transplant
sle
bmt
hodgkin
diseas
limit
conclus
deduc
respect
sle
steroid
dose
studi
look
sle
cohort
felson
et
al
compar
steroid
dose
bolu
steroid
calcul
g
prednison
equival
cumul
dose
given
month
incid
osteonecrosi
discuss
paper
includ
subsequ
section
appli
massardo
et
al
note
posit
correl
osteonecrosi
patient
treat
cumul
dose
gyear
final
bergstein
et
al
similarli
found
posit
correl
cumul
dose
overal
data
indic
correl
higher
cumul
dose
increas
risk
osteonecrosi
renal
transplant
patient
associ
corticosteroid
induc
osteonecrosi
first
describ
year
chronic
renal
failur
osteodystrophi
particularli
prone
steroid
induc
osteonecrosi
renal
transplant
patient
suffer
osteonecrosi
fortun
decreas
preval
improv
dialysi
mainten
care
numer
studi
examin
relationship
steroid
use
transplant
patient
develop
osteonecrosi
particular
interest
relationship
daili
dose
high
dose
puls
therapi
cumul
dose
risk
osteonecrosi
pertin
studi
review
outlin
tabl
studi
select
look
directli
daili
steroid
dose
potenti
risk
factor
osteonecrosi
found
statist
signific
relationship
osteonecrosi
risk
interestingli
seen
sle
studi
neg
relationship
found
studi
greater
year
old
sinc
repeat
dramat
evid
dose
relationship
risk
shibatani
et
al
perform
retrospect
analysi
renal
transplant
patient
develop
osteonecrosi
author
found
statist
signific
doserespons
associ
week
transplant
consider
correl
cumul
dose
found
describ
next
section
find
significantli
higher
daili
dose
risk
echo
multipl
studi
koo
et
al
found
high
dose
steroid
first
sever
week
import
total
cumul
dose
patton
et
al
note
mean
linear
trend
higher
daili
prednison
dose
also
statist
signific
p
b
develop
osteonecrosi
contrast
sle
data
major
studi
felson
metanalysi
renal
transplant
studi
overal
gener
consensu
among
studi
higher
daili
dose
confer
signific
risk
develop
osteonecrosi
unfortun
due
variat
among
studi
recommend
univers
safe
steroid
dose
made
situat
physician
exercis
caution
use
steroid
provid
appropri
inform
consent
higher
incid
increas
daili
cumul
dose
steroid
incid
femor
head
avn
halv
reduct
cumul
steroid
g
g
continu
next
page
renal
transplant
patient
cumul
dose
special
interest
take
account
number
renal
transplant
reject
subsequ
administr
high
dose
puls
therapi
patton
et
al
tang
et
al
hedri
et
al
de
graaf
et
al
note
statist
signific
associ
acut
reject
onset
osteonecrosi
tervoven
et
al
found
statist
signific
differ
regard
total
dose
glucocorticoid
note
trend
toward
higher
cumul
dose
occurr
fact
prior
metselaar
et
al
potter
et
al
levin
et
al
bewicktroch
et
al
also
report
predict
correl
cumul
dose
osteonecrosi
data
must
temper
methodolog
use
recent
shibatani
found
statist
signific
associ
osteonecrosi
total
dose
steroid
first
month
transplant
hedri
et
al
p
lausten
et
al
felson
et
al
morri
et
al
de
graff
et
al
pierrid
et
al
harrington
et
al
found
similar
risk
increas
cumul
dose
sever
author
demonstr
evid
increas
risk
specif
consid
cumul
iv
methylprednisolon
lausten
et
al
calcul
incid
femor
head
osteonecrosi
halv
reduct
cumul
steroid
g
g
de
graff
et
al
found
cumul
dose
greater
mg
first
month
strike
risk
bradburi
et
al
found
similar
associ
steroid
use
first
year
subsequ
risk
osteonecrosi
koo
et
al
note
daili
oral
dose
import
cumul
dose
summari
major
data
renal
transplantinduc
osteonecrosi
indic
posit
role
cumul
dose
osteonecrosi
develop
multipl
confound
variabl
play
ie
activ
inflamm
reject
may
predispos
osteonecrosi
mpsl
vs
oral
cumul
dosag
may
confer
differ
risk
risk
steroid
induc
osteonecrosi
bone
marrow
transplant
cardiac
transplant
lung
transplant
liver
transplant
acut
leukocyt
leukemia
hodgkin
diseas
multipl
myeloma
undergo
chemotherapi
sar
multipl
sclerosi
neurosurg
patient
note
tabl
third
group
studi
consist
nonren
transplant
patient
bone
marrow
transplant
n
liver
transplant
n
cardiacpulmonari
transplant
n
malign
hodgkin
n
acut
lymphoblast
leukemia
n
multipl
myeloma
n
aplast
anemia
n
sar
n
neurosurg
disord
n
organ
transplant
inevit
requir
steroid
reject
prevent
subsequ
osteonecrosi
rare
albeit
welldocu
phenomenon
found
throughout
literatur
cardiac
liver
transplant
incid
suggest
sever
author
much
lower
incid
report
renal
transplant
patient
suggest
underli
diseas
distinct
influenc
incid
steroid
induc
osteonecrosi
fortun
last
year
altern
immunosuppress
increasingli
employ
therebi
decreas
overal
need
steroid
regard
neurosurg
patient
steroid
shown
benefici
cerebr
edema
malign
mening
cord
injuri
among
other
short
cours
high
dose
corticosteroid
often
dexamethason
usual
employ
overal
incid
extract
scatter
case
report
small
studi
consider
lower
underli
diseas
discuss
thu
far
regard
underli
malign
steroid
induc
osteonecrosi
incid
vari
wide
difficult
make
gener
statement
regard
steroid
dose
vari
underli
disord
pattern
evid
studi
cardiac
liver
transplant
lieberman
et
al
found
statist
signific
relationship
daili
prednison
dose
iv
mpsl
osteonecrosi
cumul
dose
also
statist
differ
koo
et
al
suggest
high
dose
steroid
first
sever
week
seem
import
cumul
dose
major
limit
patient
solid
organ
transplant
asid
renal
bradburi
et
al
perform
retrospect
studi
found
cardiacpulmonari
transplant
patient
develop
osteonecrosi
author
demonstr
correl
cumul
dose
iv
mpsl
first
month
transplant
onset
osteonecrosi
p
summari
signific
data
make
concret
statement
regard
dose
relationship
osteonecrosi
solid
organ
transplant
though
clearli
seem
trend
toward
higher
daili
cumul
dose
talamo
et
al
found
osteonecrosi
incid
patient
multipl
myeloma
treat
antineoplast
therapi
includ
steroid
adjust
bodi
weight
cumul
dose
remain
significantli
associ
osteonecrosi
ci
p
logist
analysi
predict
cumul
dexamethason
dose
mg
chanc
induc
osteonecrosi
higher
probabl
patient
treat
cumul
dexamethason
dose
mg
acut
lymphocyt
leukemia
patient
arico
et
al
found
increas
incid
osteonecrosi
chemotherapi
regiment
cumul
dose
higher
mattano
et
al
studi
pediatr
popul
found
increas
osteonecrosi
patient
treat
dexamethason
puls
compar
receiv
one
howev
result
reach
statist
signific
vaidya
et
al
also
agre
high
cumul
dose
steroid
note
increas
risk
osteonecrosi
acut
lymphocyt
leukemia
patient
small
cohort
acut
lymphocyt
leukemia
patient
chanlam
et
al
report
patient
osteonecrosi
propos
may
explain
protocol
higher
dose
steroid
greater
convent
chemotherapi
sever
studi
state
steroid
play
role
osteonecrosi
develop
bone
marrow
transplant
paper
steroid
dose
includ
higher
cumul
dose
signific
risk
factor
develop
osteonecrosi
multivari
analysi
soci
et
al
found
factor
confer
statist
signific
risk
osteonecrosi
develop
factor
includ
chronic
gvhd
acut
gvhd
age
b
aplast
anemia
acut
leukemia
exact
steroid
dosag
address
patient
complic
treat
corticosteroid
increas
risk
osteonecrosi
enright
et
al
torri
et
al
echo
assert
also
find
increas
risk
acut
chronic
graft
vs
host
diseas
higher
cumul
steroid
dose
use
intraven
iv
puls
therapi
incid
osteonecrosi
neurosurg
patient
lower
underli
diseas
suggest
pathogenesi
osteonecrosi
involv
multihit
theori
rel
high
incid
avn
seri
could
explain
dose
corticosteroid
use
bfm
protocol
greater
dose
use
convent
chemotherapi
schedul
like
mrc
protocol
three
four
patient
develop
clinic
avn
receiv
late
intensif
block
contain
high
dose
dexamethason
would
support
role
high
dose
steroid
caus
avn
continu
next
page
author
recogn
steroid
risk
factor
care
minim
durat
dose
howev
neither
found
statist
signific
associ
daili
cumul
dose
felson
et
al
also
includ
neurosurg
studi
other
examin
studi
sar
patient
chan
et
al
conclud
cumul
dose
mg
mpsl
durat
therapi
n
day
statist
signific
risk
factor
develop
osteonecrosi
li
et
al
also
concur
high
cumul
dose
long
durat
therapi
confer
highest
risk
regard
aplast
anemia
marsh
et
al
found
osteonecrosi
occur
high
steroid
dose
group
mgkgday
vs
mgkgday
mpsl
risk
corticosteroid
develop
osteonecrosi
depend
daili
dose
cumul
dose
maximum
dose
rout
administr
well
underli
diseas
state
addit
genet
factor
yet
identifi
parenter
oral
steroid
like
lead
osteonecrosi
highest
daili
dose
lesser
extent
cumul
dose
directli
correl
risk
develop
osteonecrosi
osteonecrosi
rare
patient
short
cours
low
dose
protocol
topic
inhal
steroid
report
associ
osteonecrosi
case
confound
use
oral
parenter
steroid
well
case
osteonecrosi
found
associ
use
topic
inhal
steroid
alon
unfortun
minor
affect
case
ever
report
due
absenc
subject
object
find
initi
phase
diseas
earli
diagnosi
osteonecrosi
depend
abil
physician
maintain
high
index
suspicion
symptom
present
diseas
may
alreadi
progress
phase
irrevers
damag
treatment
later
stage
diseas
suboptim
invari
involv
surgic
procedur
includ
total
hip
replac
current
guidelin
defin
safe
threshold
dose
steroid
paper
attempt
establish
recommend
administr
steroid
mani
case
use
steroid
unavoid
know
likelihood
develop
osteonecrosi
complic
steroid
use
may
help
earli
detect
condit
risk
osteonecrosi
corticosteroid
remain
signific
caus
morbid
physician
awar
risk
patient
inform
consum
corticosteroid
prescrib
inde
suggest
follow
recommend
health
care
provid
awar
potenti
risk
osteonecrosi
patient
treat
corticosteroid
especi
parenter
oral
prepar
certain
specif
underli
diseas
state
patient
receiv
steroid
via
rout
ia
inhal
intranas
low
zero
risk
develop
osteonecrosi
potenti
develop
osteonecrosi
high
dose
inhal
corticosteroid
use
sever
persist
asthma
eosinophil
esophag
patient
alway
inform
risk
develop
osteonecrosi
whenev
steroid
use
complet
understand
pathogenesi
osteonecrosi
may
help
us
establish
precis
guidelin
futur
use
therapeut
checklist
propos
weldon
et
al
may
use
mean
identifi
patient
particular
risk
minim
whenev
abl
use
steroid
everi
decis
crossroad
corticosteroid
remain
lifesav
medic
carri
risk
factor
includ
potenti
develop
osteonecrosi
patient
autoimmun
diseas
increas
risk
osteonecrosi
carri
increas
burden
secondari
use
corticosteroid
physician
awar
complic
earlier
diagnosi
may
lead
significantli
improv
outcom
risk
develop
osteonecrosi
dose
durat
depend
clearli
individu
differ
explain
differ
patient
suscept
develop
complic
